March 2012

Click to download the PDF to view the full issue

March 1, 2012/by Administrator

Share this entry

https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Administrator https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Administrator2012-03-01 12:12:312015-03-15 12:16:05March 2012

Recent

Supreme Court turns away challenge to U.S. vaccine rule...October 3, 2022 - 10:13 am
AstraZeneca acquires LogicBio for $68 million to bolster...October 3, 2022 - 10:09 am
U.S. Supreme Court turns away Biogen bid to reinstate MS...October 3, 2022 - 10:08 am
Amylyx and ALS researchers look to build on Relyvrio mo...October 3, 2022 - 9:30 am

Popular

Supreme Court turns away challenge to U.S. vaccine rule...October 3, 2022 - 10:13 am
M&A, Partnerships And CollaborationsJanuary 1, 2011 - 1:48 pm
OTC Review And OutlookMarch 9, 2011 - 4:17 pm
Global Contract Manufacturing Companies: Pharmaceutical...November 11, 2011 - 3:31 pm

Tags

AbbVie AstraZeneca Bavarian Nordic Biogen BioNTech Bristol-Myers Squibb Business cancer clinical trials Covid-19 COVID-19 pandemic COVID-19 vaccines Data European Union FDA featured GSK healthcare communications Healthcare Communications Agencies Joe Biden Johnson & Johnson Merck & Co. Moderna monkeypox monkeypox vaccine Novartis omicron Omicron subvariants Omicron variant Oncology Paxlovid people on the move Pfizer public health emergency R&D rare disease Roche Sanofi U.S. Centers for Disease Control and Prevention (CDC) U.S. Food and Drug Administration (FDA) United States Vaccines WHO World Health Organization zoonotic diseases

Fenruary 2012 April 2012

Scroll to top